Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
92 pending office actions • 54 art units • 86 examiners • 0 of 92 (0%) have an AI response strategy ready • 67 patents granted in the last 365 days
The Trustees Of Columbia University In The City Of New York City currently have 1 pending office action. This matter falls within the Semiconductors, Circuits & Optics technology area and is assigned to 1 distinct art unit. JUNG, JONATHAN Y is the busiest examiner with 1 pending action, and as the only 1 distinct examiner involved, they oversee the full scope of the university's current pending prosecution. This single pending office action represents a highly concentrated point of review for the university's semiconductor research.
Based on the USPTO statutory response window for each pending office action. 27 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 27 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 10 (11%) |
| §103 only | 19 (21%) |
| §102 only | 3 (3%) |
| §112 only | 4 (4%) |
| Double-patenting only | 3 (3%) |
| Double-patenting + other | 7 (8%) |
| Multi-statute (no §101) | 46 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MEAH, MOHAMMAD Y | 2 | 70.8% | +42.7% |
| WANG, JING | 2 | 100.0% | +0.0% |
| POLIAKOVA-GEORGAN, EKATERINA | 2 | 64.0% | +18.0% |
| SWITZER, JULIET CAROLINE | 2 | 42.4% | +54.0% |
| MOORE, SUSANNA | 2 | 68.0% | +31.5% |
| LEE, JAE W | 2 | 65.9% | +38.7% |
| MIAH, RAZU A | 1 | 84.7% | +25.9% |
| BRUCE, FAROUK A | 1 | 49.5% | +39.2% |
| NASH, GARY A | 1 | 88.9% | +4.7% |
| BERHANE, ADOLF D | 1 | 88.4% | -1.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18393267 | PHOTONICALLY INTEGRATED ATOMIC TWEEZER CLOCK | WANG, JING | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18115402 | Wearable Engineered Human Skin and Systems and Methods for Making the Same | TICHY, JENNIFER M.H. | 71d overdue |
| 18178192 | AGENTS FOR THE TREATMENT OF DISEASES BY INHIBITION OF FOXO1 | FETTEROLF, BRANDON J | 56d overdue |
| 18017000 | IBOGAINE ANALOGS AS THERAPEUTICS FOR NEUROLOGICAL AND PSYCHIATRIC DISORDERS | MOORE, SUSANNA | 36d overdue |
| 18121311 | CAVITY-SEPARATED MULTI-NANOPORE DEVICE AND METHOD PROVIDING PROTEIN SEQUENCING | SINES, BRIAN J | 30d overdue |
| 17092975 | BACTERIAL CAPTURE SEQUENCING PLATFORM AND METHODS OF DESIGNING, CONSTRUCTING AND USING | LIU, GUOZHEN | 19d overdue |
| 17928674 | COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS USING CRISPR-BASED BASE EDITOR SYSTEMS | WESTON, ALYSSA G | 16d overdue |
| 18244847 | WIRELESS AND RETROFITTABLE IN-SHOE SYSTEM FOR REAL-TIME ESTIMATION OF KINEMATIC AND KINETIC GAIT PARAMETERS | FERNANDES, PATRICK M | 4d overdue |
| 17849565 | BIOHYBRID HEART VALVE REPLACEMENT | GANESAN, SUBA | 7d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18017000 | IBOGAINE ANALOGS AS THERAPEUTICS FOR NEUROLOGICAL AND PSYCHIATRIC DISORDERS | MOORE, SUSANNA | 36d overdue |
| 18990861 | SYSTEMS AND METHODS FOR PROVIDING AUGMENTED ULTRASONOGRAPHY WITH AN IMPLANTED ELECTRONIC DEVICE | BRUCE, FAROUK A | 32d overdue |
| 19228510 | SYSTEMS, METHODS, AND MEDIA FOR IMPLEMENTING NETWORK CONGESTION CONTROL | MIAH, RAZU A | — |
| 18984297 | MODIFIED BACTERIAL PROTEIN EXPRESSION SYSTEM | MEAH, MOHAMMAD Y | — |
| 18570914 | SYSTEMS, METHODS, AND COMPONENTS FOR RNA-GUIDED EFFECTOR RECRUITMENT | POLIAKOVA-GEORGAN, EKATERINA | — |
| 18565854 | UNIQUE CANCER ASSOCIATED FIBROBLAST SUBSETS PREDICT RESPONSE TO IMMUNOTHERAPY | SWITZER, JULIET CAROLINE | — |
| 18459733 | Methods To Analyze Methylomes In Tumor And Plasma Cell-Free DNA | SWITZER, JULIET CAROLINE | — |
| 18366544 | OXA- IBOGAINE INSPIRED ANALOGUES FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS | MOORE, SUSANNA | — |
| Art Unit | Apps |
|---|---|
| 3797 | 3 |
| 1622 | 3 |
| 1637 | 3 |
| 2838 | 2 |
| 2896 | 2 |
| 1682 | 2 |
| 1634 | 2 |
| 3798 | 2 |
| 1681 | 2 |
| 3791 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19228510 | SYSTEMS, METHODS, AND MEDIA FOR IMPLEMENTING NETWORK CONGESTION CONTROL | MIAH, RAZU A | — | §103§112 | Non-Final OA | — | Pending | Jun 04, 2025 |
| 18990861 | SYSTEMS AND METHODS FOR PROVIDING AUGMENTED ULTRASONOGRAPHY WITH AN IMPLANTED ELECTRONIC DEVICE | BRUCE, FAROUK A | 3797 | §103 | Final Rejection | 32d overdue | Pending | Dec 20, 2024 |
| 18984297 | MODIFIED BACTERIAL PROTEIN EXPRESSION SYSTEM | MEAH, MOHAMMAD Y | — | §112 | Non-Final OA | — | Pending | Dec 17, 2024 |
| 18873869 | THERMAL MANAGEMENT SYSTEMS AND METHODS FOR POWER DEVICES | NASH, GARY A | 2838 | §102§103 | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18975635 | Systems and Methods for Power Conversion Using Controllable Converters | BERHANE, ADOLF D | — | §102§103 | Non-Final OA | — | Pending | Dec 10, 2024 |
| 18967738 | GENERATION OF LUNG ORGANOIDS FROM PLURIPOTENT STEM CELLS AND USE THEREOF | KIM, TAEYOON | — | §103§112 | Non-Final OA | — | Pending | Dec 04, 2024 |
| 18900035 | TREATMENT OF NEURODEGENERATIVE DISEASES VIA ADMINISTRATION OF BUNTANETAP AND A PHOSPHODIESTERASE INHIBITOR | SHIAO, REI TSANG | — | §103§112 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18826257 | Microneedle Mediated Intracochlear Delivery | KASHYAP, ESHA PRAKASH | — | §103§112 | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18823256 | METASURFACE HOLOGRAPHIC OPTICAL TRAPS FOR ULTRACOLD ATOMS | WANG, JING | — | §102§103§112 | Non-Final OA | — | Pending | Sep 03, 2024 |
| 18820857 | Systems and Methods for Efficient Trainable Template Optimization on Low Dimensional Manifolds for Use in Signal Detection | TO, BAOQUOC N | — | §101§103 | Non-Final OA | — | Pending | Aug 30, 2024 |
| 18819967 | METHODS AND COMPOSITIONS TO REGULATE MAPT SPLICING FOR MODELING AND TREATMENT OF TAUOPATHIES | KIEFER, DALTON EDWARD | — | §103§112 | Non-Final OA | — | Pending | Aug 29, 2024 |
| 18811230 | SYSTEMS, METHODS, AND MEDIA FOR ESTABLISHING AUTHENTICITY OF IMAGE CONTENT | KNACKSTEDT, JACOB BENEDICT | — | §103§112 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18781034 | ALDOSE REDUCTASE INHIBITORS AND METHODS OF USE THEREOF | COUGHLIN, MATTHEW P | — | DP | Non-Final OA | — | Pending | Jul 23, 2024 |
| 18779934 | MAGNETIC RESONANCE APPARATUS, COMPUTER-ACCESSIBLE MEDIUM, SYSTEM AND METHOD FOR USE THEREOF | JASANI, ASHISH SHIRISH | 2896 | §102§103§112 | Non-Final OA | — | Pending | Jul 22, 2024 |
| 18772735 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF VASCULAR MALFORMATIONS | KATAKAM, SUDHAKAR | — | §112 | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18745839 | SYSTEMS, METHODS, AND MEDIA FOR VERIFYING SOFTWARE | SU, SARAH | — | §102§103 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18635627 | COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS | GANGLE, BRIAN J | 1645 | §102§112DP | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18622162 | METHOD FOR MODULATING UNPRODUCTIVE ALTERNATIVE SPLICING | HUDSON, AMY ROSE | — | §102§103§112 | Non-Final OA | — | Pending | Mar 29, 2024 |
| 18603989 | Devices, Methods, and Systems for Gait Modification | KHONG, BRIAN THAI-BINH | — | §103§112 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18596300 | METHODS OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE INCLUDING COMPOUNDS USEFUL THEREIN | KIM, SEONG JONG | 1621 | §102§103§112 | Non-Final OA | — | Pending | Mar 05, 2024 |
| 18430804 | Novel Deformable Mechanism For Robotic Propulsion, Manipulation And Other Devices | RUSHING, JR, BOBBY | 3618 | §102§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18292317 | SYSTEMS AND METHODS FOR POWER CONVERSION WITH LC FILTER HAVING AN INDUCTOR WITH BOARD-EMBEDDED WINDING | CAULK, JENNIFER CHRISTINE | 2838 | §103 | Non-Final OA | — | Pending | Jan 25, 2024 |
| 18291530 | CHARACTERIZATION OF POTENT AND BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST SARS-COV-2, ITS VARIANTS, AND RELATED CORONAVIRUSES AND METHODS OF USE | PARKIN, JEFFREY S | — | §112 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18417066 | SYSTEM, METHOD, AND COMPUTER-ACCESSIBLE MEDIUM FOR POINT PROCESSES FOR COMPETING OBSERVATIONS WITH RECURRENT NETWORKS | JUNG, DONG YOON | — | §101§103 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18408545 | SYSTEMS AND METHODS FOR MASS SENSING BASED ON INTEGRATED, FUNCTIONALIZED PIEZOELECTRIC RESONATORS | WALSH, RYAN D | 2852 | §102§103 | Final Rejection | 16d | Pending | Jan 09, 2024 |
| 18393267 | PHOTONICALLY INTEGRATED ATOMIC TWEEZER CLOCK | WANG, JING | 2881 | §103 | Final Rejection | — | Pending | Dec 21, 2023 |
| 18570914 | SYSTEMS, METHODS, AND COMPONENTS FOR RNA-GUIDED EFFECTOR RECRUITMENT | POLIAKOVA-GEORGAN, EKATERINA | — | §101§102§103§112DP | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18565854 | UNIQUE CANCER ASSOCIATED FIBROBLAST SUBSETS PREDICT RESPONSE TO IMMUNOTHERAPY | SWITZER, JULIET CAROLINE | 1682 | §103§112DP | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18522460 | SYSTEMS AND METHODS FOR DISASSEMBLING TWO-DIMENSIONAL VAN DER WAALS CRYSTALS INTO MACROSCOPIC MONOLAYERS AND REASSEMBLING INTO ARTIFICIAL LATTICES | FERGUSON, LAWRENCE D | 1781 | §102§103 | Non-Final OA | 33d | Pending | Nov 29, 2023 |
| 18514836 | CHIMERIC NANOBODY COMPOSITIONS AND METHODS OF TREATMENT THEREOF | REDDIG, PETER J | — | §102§103§112 | Non-Final OA | — | Pending | Nov 20, 2023 |
| 18507851 | TUMOR IMMUNOTHERAPY | SHIAO, YIH-HORNG | 1691 | §101§102§112 | Non-Final OA | — | Pending | Nov 13, 2023 |
| 18498383 | Programmable Nanoencapsulation for Delivery of Probiotics in Vivo | TINSLEY, BRENDAN THOMAS | 1634 | §103§112 | Non-Final OA | — | Pending | Oct 31, 2023 |
| 18287557 | DEGRADABLE WASTE PROCESSING | SPIES, BRADLEY R | 1777 | §103 | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18481551 | Magnetic Resonance Spectroscopy Frequency and Phase Correction | CELESTINE, NYROBI I | 3798 | §103 | Final Rejection | 40d | Pending | Oct 05, 2023 |
| 18467510 | RNA PRINTING AND SEQUENCING DEVICES, METHODS, AND SYSTEMS | WILDER, CYNTHIA B | 1681 | §103 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18244847 | WIRELESS AND RETROFITTABLE IN-SHOE SYSTEM FOR REAL-TIME ESTIMATION OF KINEMATIC AND KINETIC GAIT PARAMETERS | FERNANDES, PATRICK M | 3791 | §101§112DP | Final Rejection | 4d overdue | Pending | Sep 11, 2023 |
| 18459733 | Methods To Analyze Methylomes In Tumor And Plasma Cell-Free DNA | SWITZER, JULIET CAROLINE | 1683 | §103§112 | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18234482 | Mobile Tethered Pelvic Assist Device for Generating Timed Frontal Plane Pelvic Moments During Overground Walking | TOICH, SARA KATHERINE | 3785 | §101§102§103§112 | Non-Final OA | 34d | Pending | Aug 16, 2023 |
| 18006212 | Precision Targeted Retromer Therapeutics for the Treatment of Neurodegenerative Diseases and Disorders | BUCCINI, MICHELLE CALLAHAN | 1675 | §103§112DP | Non-Final OA | — | Pending | Aug 11, 2023 |
| 18366544 | OXA- IBOGAINE INSPIRED ANALOGUES FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS | MOORE, SUSANNA | 1624 | §102§103 | Non-Final OA | — | Pending | Aug 07, 2023 |
| 18362365 | Methods for Cardiac Differentiation of Human Induced Pluripotent Stem Cells | MOLOYE, TITILAYO | 1632 | §101§103 | Final Rejection | — | Pending | Jul 31, 2023 |
| 18359651 | SYNTHESIS OF COMPLEX 15N-LABELED MOLECULES | DEKARSKE, MADELINE MCGUIRE | 1622 | §103§112 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18223327 | METHODS FOR TREATING GRAFT-VERSUS-HOST DISEASE USING GLP-2 AGONISTS AND ANALOGUES THEREOF | VARADARAJ, ARCHANA | 1658 | §103 | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18217812 | ENCODING AN ASSEMBLY OF THREE-DIMENSIONAL HIERARCHICALLY ORGANIZED NANOPARTICLE ARCHITECTURES THROUGH CHROMATIC BONDS | WOITACH, JOSEPH T | — | §101§103 | Non-Final OA | — | Pending | Jul 03, 2023 |
| 18339789 | SYSTEMS AND METHODS FOR MULTIMODAL PROFILING | OLSON, ALEXANDRA NADINE | 1684 | §103 | Final Rejection | 60d overdue | Pending | Jun 22, 2023 |
| 18318231 | INTEGRATED METASURFACES FOR FREE-SPACE WAVEFRONT GENERATION WITH COMPLETE AMPLITUDE, PHASE, AND POLARIZATION CONTROL | TAVLYKAEV, ROBERT FUATOVICH | 2896 | §103 | Non-Final OA | — | Pending | May 16, 2023 |
| 18197134 | SYSTEMS AND METHODS FOR IDENTIFYING RANSOMWARE ACTORS IN DIGITAL CURRENCY NETWORKS | KING, DAVIDA LEE | 3699 | §103 | Final Rejection | — | Pending | May 15, 2023 |
| 18036708 | SYSTEMS FOR PUMP-FREE ZINC BROMIDE BATTERIES | KASS-MULLET, BENJAMIN ELI | 1752 | §103 | Final Rejection | 44d overdue | Pending | May 12, 2023 |
| 18124822 | SYSTEMS AND METHODS FOR THE BINDING OF RARE EARTH ELEMENTS BY BETA ROLL PEPTIDES | LEE, JAE W | 1656 | §103§112 | Non-Final OA | — | Pending | Mar 22, 2023 |
| 18121759 | USE OF ANTI-CRISPR AGENTS TO CONTROL EDITING IN HUMAN EMBRYOS | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103§112 | Final Rejection | — | Pending | Mar 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Trustees of Columbia University in the City of New York has 92 pending office actions as of October 2026, spread across 54 art units and 86 examiners.
Mohammad Y Meah has the most, with 2 of The Trustees of Columbia University in the City of New York's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.